Massage
OtherMassage the trigger points in 8 different points for 1 min in circle direction and 3 times a day.
NCT Number: NCT04232046
Patients with IHS criteria of chronic tension headache , considering inclusion and exclusion criteria, enrolled to this study. They will be randomized to intervention or control group by block randomization method, then treat by standard drug( nortriptyline 10 mg daily) or trigger point massage.
They report severity, frequency, duration of headaches and number of analgesic drugs in diary during week 1 and week 4. Then data based on dairy will be analysis.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Massage the trigger points in 8 different points for 1 min in circle direction and 3 times a day.
Time frame: Mean Visual Analogue Scale sore change in week 4 from the baseline
By Visual Analogue Scale score,from 0 that indicate no pain to 10 that indicate severe pain
Time frame: Change in number of attacks in week 4 from the base line
Number of attacks in week
Time frame: Change in Time duration in week 4 from the baseline
Time duration ( in minutes)of attacks in week
Time frame: Change in Number of analgesic drugs used in week 4 from the baseline
Number of analgesic drugs used during a week
Mazandaran University of Medical Sciences
Other
Efficacy of Trigger Points Massage in Severity of Chronic Tension Headache:An Unmasked, Randomized, Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04867967
Brain Diseases, Central Nervous System Diseases
Essen, North Rhine-Westphalia, Germany
View Trial DetailsNCT04857671
Brain Diseases, Central Nervous System Diseases
Namsos, Norway
View Trial DetailsNCT06604637
Brain Diseases, Central Nervous System Diseases
Bitlis, Turkey (Türkiye)
View Trial DetailsNCT06155669
Agnosia, Analgesia
Ankara, Çankaya, Turkey (Türkiye)
View Trial Details